C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2011
10/19/2011	CN102219725A Benzohetercyclic compound as well as preparation method and applications thereof
10/19/2011	CN101696205B 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
10/19/2011	CN101384577B Novel coumarin derivative having antitumor activity
10/19/2011	CN101367792B Benzotriazole light stabilizer containing hindered amine group
10/19/2011	CN101180296B Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
10/18/2011	US8039636 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
10/18/2011	US8039631 Process for preparing crystalline form A of Lansoprazole
10/18/2011	US8039630 Cationic compound, dye compound and method of using the same, and optical information recording medium
10/18/2011	US8039622 Melanocortin receptor agonists
10/18/2011	US8039498 Imidazole compounds
10/18/2011	US8039489 Guanidine-containing compounds useful as muscarinic receptor antagonists
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039487 Piperidine-amide derivatives
10/18/2011	US8039486 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
10/18/2011	US8039485 Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
10/18/2011	US8039471 Aza spiro alkane derivatives as inhibitors of metalloproteases
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	US8039466 5-hydroxymethyl-oxazolidin-2-one antibacterials
10/18/2011	US8039462 Methods and compositons for stimulating neurogenesis and inhibiting neuronal degeneration
10/18/2011	US8039125 Compound comprising phenyl pyridine units
10/18/2011	CA2598294C Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
10/18/2011	CA2494049C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2443950C Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/18/2011	CA2360275C Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/13/2011	WO2011127406A2 Acridines as inhibitors of haspin and dyrk kinases
10/13/2011	WO2011127388A2 Inverse agonists and neutral antagonists for the tsh receptor
10/13/2011	WO2011127106A1 Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators
10/13/2011	WO2011127051A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/13/2011	WO2011126903A2 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	WO2011126544A2 Thymoquinone analogs for the treatment of pancreatic cancer
10/13/2011	WO2011125838A1 Therapeutic agent or preventive agent for urine collection disorder
10/13/2011	WO2011125836A1 Therapeutic agent or prophylactic agent for fibromyalgia
10/13/2011	WO2011125317A1 Triazole derivative and pest control agent
10/13/2011	WO2011124930A1 P38 map kinase inhibitors
10/13/2011	WO2011124923A2 Novel compounds
10/13/2011	WO2011124713A1 Labelled huprine derivatives and their use in medical imaging
10/13/2011	WO2011124712A1 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
10/13/2011	WO2011124580A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	WO2011124249A1 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts
10/13/2011	WO2011123937A1 Kinase inhibitors and method of treating cancer with same
10/13/2011	WO2011091840A3 Materials for organic electroluminescent devices
10/13/2011	WO2011086412A3 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof
10/13/2011	WO2010069502A8 Tetrazole substituted anthranilic acid amides as pesticides
10/13/2011	WO2010058409A3 Optical purification of esomeprazole
10/13/2011	US20110251399 Method for producing aldehydes and ketones from primary and secondary alcohols
10/13/2011	US20110251394 Novel organic compound
10/13/2011	US20110251390 Nicotine-based compounds useful for asymmetric synthesis
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251237 2,5-Disubstituted Piperidine Orexin Receptor Antagonists
10/13/2011	US20110251236 Galactokinase inhibitors
10/13/2011	US20110251221 Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators
10/13/2011	US20110251212 Piperazine derivatives
10/13/2011	US20110251210 Modified chloroquines with single ring moiety or fused ring moiety
10/13/2011	US20110251208 Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
10/13/2011	US20110251199 Nitrogen-containing bicyclic heteroaryl compounds and methods of use
10/13/2011	US20110251194 Antineoplastic derivatives, preparation thereof and therapeutic use thereof
10/13/2011	US20110251181 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251178 Bicyclic Pyridinylpyrazoles
10/13/2011	US20110251176 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	US20110251174 2,4-diamino-pyrimidines as aurora inhibitors
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251169 Arylethynyl derivatives
10/13/2011	US20110251168 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/13/2011	US20110251160 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
10/13/2011	US20110251158 Fullerene therapies for inflammation and inhibition of build-up of arterial plaque
10/13/2011	US20110251069 Isoxazole derivatives for use as plant growth regulators
10/13/2011	US20110250273 Compositions of proton pump inhibitors, kits and methods of their use to treat diabetes
10/13/2011	US20110248257 Compound for an organic photoelectric device, organic photoelectric device, and display device including the same
10/13/2011	CA2829790A1 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	CA2795866A1 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
10/13/2011	CA2795732A1 Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators
10/13/2011	CA2795514A1 Novel hypoglycemic compounds
10/13/2011	CA2795513A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/13/2011	CA2794801A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	CA2794252A1 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts
10/13/2011	CA2793730A1 Therapeutic agent or preventive agent for urine collection disorder
10/13/2011	CA2793709A1 Therapeutic agent or prophylactic agent for fibromyalgia
10/13/2011	CA2789818A1 Inverse agonists and neutral antagonists for the tsh receptor
10/12/2011	EP2374805A1 Crystals of hydrochloride of pyridazin-3(2h)-one compound and process for production of same
10/12/2011	EP2374804A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/12/2011	EP2374795A1 Sulphonic acid derivatives of polycyclic dyes used for analytical applications
10/12/2011	EP2374454A1 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/12/2011	EP2373646A1 Phthalazinone and related analogs as sirtuin modulators
10/12/2011	EP2373640A1 Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
10/12/2011	EP2373639A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
10/12/2011	EP2373634A1 Morpholinone compounds as factor ixa inhibitors
10/12/2011	EP2373631A2 Antibacterial compounds
10/12/2011	EP2373629A1 Compounds for treating cancer
10/12/2011	EP2373627A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
10/12/2011	EP2373626A1 Substituted indazole derivatives active as kinase inhibitors
10/12/2011	EP2373620A1 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/12/2011	EP2373618A2 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
10/12/2011	EP2373313A1 Substituted pyrazole compounds
10/12/2011	EP2373165A1 Substituted dioxopiperidinyl phthalimide derivaties
10/12/2011	EP2229356B1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis

1 ... 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 ... 1080